Literature DB >> 4942761

Mechanism of action of rifampin on Mycobacterium smegmatis.

R J White, G C Lancini, L G Silvestri.   

Abstract

Deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase (EC 2.7.7.6) isolated from a rifampin-sensitive strain of Mycobacterium smegmatis was 90% inhibited by 1 mug of rifampin per ml; enzyme from a rifampin-resistant mutant was not affected by this concentration of antibiotic. Inhibition of phenylalanine-1-(14)C incorporation by rifampin in growing cultures was complete about 6 min after addition of antibiotic. Under the same conditions, uracil-2-(14)c incorporated was blocked after 1.5 to 2 min. Rifampin kills M. smegmatis very slowly. When rifampin-inhibited cultures were transferred to a rifampin-free medium, there was a partial resumption of uracil-2-(14)C incorporation, even in the presence of chloramphenicol. We conclude that a primary event in the inhibition of M. smegmatis by rifampin is the block of DNA-dependent RNA polymerase.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4942761      PMCID: PMC247133          DOI: 10.1128/jb.108.2.737-741.1971

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  16 in total

1.  Rifampicin: a new rifamycin. I. Bacteriological studies.

Authors:  V Arioli; R Pallanza; S Furesz; G Carniti
Journal:  Arzneimittelforschung       Date:  1967-05

2.  A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  R R Burgess
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

3.  Mutant of E. coli containing an altered DNA-dependent RNA polymerase.

Authors:  G P Tocchini-Valentini; P Marino; A J Colvill
Journal:  Nature       Date:  1968-10-19       Impact factor: 49.962

4.  Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria.

Authors:  W Wehrli; F Knüsel; M Staehelin
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

5.  Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.

Authors:  R Pallanza; V Arioli; S Furesz; G Bolzoni
Journal:  Arzneimittelforschung       Date:  1967-05

6.  RNA polymerase mutants blocked in sporulation.

Authors:  A L Sonenshein; R Losick
Journal:  Nature       Date:  1970-08-29       Impact factor: 49.962

7.  The control of ribonucleic acid synthesis in bacteria. The synthesis and stbility of ribonucleic acid in rifampicin-inhibited cultures of Escherichia coli.

Authors:  W J Gray; J E Midgley
Journal:  Biochem J       Date:  1971-04       Impact factor: 3.857

8.  Bacillus subtilis mutant altered in spore morphology and in RNA polymerase activity.

Authors:  R H Doi; L R Brown; G Rodgers; Y Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

9.  Rifampicin inhibition of ribonucleic acid and protein synthesis in normal and ethylenediaminetetraacetic acid-treated Escherichia coli.

Authors:  P Reid; J Speyer
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

10.  Rifamycins LXI: in vivo inhibition of RNA synthesis of rifamycins.

Authors:  G C Lancini; G Sartori
Journal:  Experientia       Date:  1968-11-15
View more
  14 in total

1.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 2.  Intermediary metabolism of mycobacteria.

Authors:  T Ramakrishnan; P S Murthy; K P Gopinathan
Journal:  Bacteriol Rev       Date:  1972-03

3.  Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  T Yamada; A Nagata; Y Ono; Y Suzuki; T Yamanouchi
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

4.  Tryptophan uptake by Mycobacterium tuberculosis H37Rv: effect of rifampin and ethambutol.

Authors:  K S Sundaram; T A Venkitasubramanian
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Rapid radiometric method of testing susceptibility of mycobacteria and slow-growing fungi to antimicrobial agents.

Authors:  P Benitez; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

Review 6.  Cure of tuberculosis using nanotechnology: An overview.

Authors:  Rout George Kerry; Sushanto Gouda; Bikram Sil; Gitishree Das; Han-Seung Shin; Gajanan Ghodake; Jayanta Kumar Patra
Journal:  J Microbiol       Date:  2018-05-02       Impact factor: 3.422

7.  Lethal effect of rifampicin in Bacillus subtilis as a complicating factor in the assessment of the lifetime of messenger ribonucleic acid.

Authors:  J G Coote; D A Wood; J Mandelstam
Journal:  Biochem J       Date:  1973-05       Impact factor: 3.857

8.  Susceptibility of mycobacteria to rifampin.

Authors:  C L Woodley; J O Kilburn; H L David; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

9.  Inhibition of the incorporation of 14C-precursors in Mycobacterium smegmatis by antibiotics and chemotherapeutics.

Authors:  V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1982       Impact factor: 2.099

10.  The effect of rifampicin on Mycobacterium smegmatis.

Authors:  V Majtán; M Miko
Journal:  Folia Microbiol (Praha)       Date:  1982       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.